01 2Gowling Lafleur Henderson LLP
02 2Hoffmann-La Roche Limited
01 21327358
02 22103324
01 4Capecitabine
01 4Tablet
01 22011-03-01
02 22013-11-17
Patent Expiration Date : 2011-03-01
Date Granted : 1994-03-01
Brand Name : XELODA
Patent Number : 1327358
Filing Date : 1988-11-02
Strength per Unit : 150 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2011-03-01
Date Granted : 1994-03-01
Patent Expiration Date : 2011-03-01
Date Granted : 1994-03-01
Brand Name : XELODA
Patent Number : 1327358
Filing Date : 1988-11-02
Strength per Unit : 500 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2011-03-01
Date Granted : 1994-03-01
Patent Expiration Date : 2013-11-17
Date Granted : 1997-12-23
Brand Name : XELODA
Patent Number : 2103324
Filing Date : 1993-11-17
Strength per Unit : 150 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2013-11-17
Date Granted : 1997-12-23
Patent Expiration Date : 2013-11-17
Date Granted : 1997-12-23
Brand Name : XELODA
Patent Number : 2103324
Filing Date : 1993-11-17
Strength per Unit : 500 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2013-11-17
Date Granted : 1997-12-23
LOOKING FOR A SUPPLIER?
Market Place
